China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in China SXT Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 4
- −4 vs. Q3 2023
- Shares held
- 50.5K
- −430.0K (−89.5%) vs. Q3 2023
- Total value
- $199.4K
- +$142.3K (+249.6%) vs. Q3 2023
- New holders
- 1
- 0 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SXTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $6 |
| Q1 2026 | 4 | $131.3K |
| Q4 2025 | 8 | $524.0K |
| Q3 2025 | 10 | $490.6K |
| Q2 2025 | 4 | $132.6K |
| Q1 2025 | 2 | $13.1K |
| Q4 2024 | 3 | $5.08K |
| Q3 2024 | 7 | $30.0K |
| Q2 2024 | 7 | $79.9K |
| Q1 2024 | 4 | $3.19K |
| Q4 2023 | 4 | $199.4K |
| Q3 2023 | 8 | $57.0K |
| Q2 2023 | 4 | $32.3K |
| Q1 2023 | 6 | $65.5K |
| Q4 2022 | 5 | $138.9K |
| Q3 2022 | 5 | $66.0K |
| Q2 2022 | 4 | $78.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding China SXT Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marex Group plc | 41,293 | $163.9K | 0.01% | +41,293 | New |
| UBS Group AG | 6,408 | $25.4K | 0.00% | −23,462−78.5% | Reduced |
| Acadian Asset Management LLC | 2,759 | $10.0K | 0.00% | −102,280−97.4% | Reduced |
| Qube Research & Technologies Ltd | 3 | $12 | 0.00% | −47−94.0% | Reduced |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −191,339−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −49,965−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −42,771−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −48,507−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −12,916−100.0% | Sold out |